OpenVSafe by OpenVAERS
Search V-safe

4T2-32669-30422

2 vaccinations 5 coded responses 23 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
462 / IN
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-07
    Registered in v-safe
  3. 2021-01-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness
    Adult check-in
  4. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness
    Adult check-in
  5. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness
    Adult check-in
  6. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-01-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dyspnoea, Oxygen saturation decreased, Tachycardia — Feeling: Fair · Fatigue or tiredness
    Free text: Tachycardia, difficulty taking deep breath intermittently with slightly decreased SpO2 just like I had during Covid illness .
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dyspnoea, Pre-existing disease — Feeling: Fair · Fatigue or tiredness
    Free text: Difficulty breathing , intermittent , had to use an inhaler . Similar to my acute covid symptoms in March but much milder
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-13
    Health check-in — day 7, dose 1
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2021-01-20
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-27
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-29
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  14. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  15. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Palpitations — Feeling: Fair · Fatigue or tiredness
    Free text: Palpitations
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Chills
    Adult check-in
  18. 2021-02-05
    Health check-in — day 7, dose 2
    Feeling: Good · Chills
    Adult check-in
  19. 2021-02-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-21
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-27
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-12
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-05-01
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-07-30
    Survey response — 6 months, dose 2
    MedDRA: Condition aggravated, Dyspnoea, Dyspnoea exertional, Exercise tolerance decreased, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Frequent flares of cold sores and shingles . Shortness of breath on exertion and increased exercise intolerance .
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-07-30
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-08-12
  28. 2022-01-29
    Survey response — 12 months, dose 2
    MedDRA: Arthritis, Exposure to SARS-CoV-2, Herpes zoster, Viral rash, Weight increased — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Significant weight gain Shingles outbreak Inflammatory arthritis Viral exanthem after Covid exposure
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-01-29
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  30. 2022-02-01
  31. 2022-02-02

Vaccinations

DoseDateManufacturerCo-administered
12021-01-06Pfizer-BioNTech
22021-01-29Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-11

Systemic reaction (other): Tachycardia, difficulty taking deep breath intermittently with slightly decreased SpO2 just like I had during Covid illness .

2021-01-12

Systemic reaction (other): Difficulty breathing , intermittent , had to use an inhaler . Similar to my acute covid symptoms in March but much milder

Release 3 — days 1–6 daily, dose 2

2021-02-03

Systemic reaction (other): Palpitations

Release 9 — 6 months, dose 2

2021-07-30

Symptoms: Frequent flares of cold sores and shingles . Shortness of breath on exertion and increased exercise intolerance .

Release 11 — 12 months, dose 2

2022-01-29

Symptoms: Significant weight gain Shingles outbreak Inflammatory arthritis Viral exanthem after Covid exposure

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthritis · · ✓
SDCondition aggravated ✓ · ✓
SDDyspnoea ✓ · ✓
SDDyspnoea exertional ✓ · ✓
SDExercise tolerance decreased ✓ · ✓
SDExposure to SARS-CoV-2 · · ✓
SDHerpes zoster · · ✓
SDPre-existing disease ✓ · ✓
SDViral rash · · ✓
SDWeight increased · · ✓
SRODyspnoea ✓ ✓ ✓
SROOxygen saturation decreased ✓ ✓ ✓
SROPalpitations ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROTachycardia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release